A Study to Evaluate the Adjustment Function of a Modified Spatz3 Adjustable Balloon (Spatz4). - Trial NCT06373666
Access comprehensive clinical trial information for NCT06373666 through Pure Global AI's free database. This phase not specified trial is sponsored by Spatz FGIA, Inc and is currently Not yet recruiting. The study focuses on Overweight and Obesity. Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Spatz FGIA, Inc
Timeline & Enrollment
N/A
Jun 01, 2024
Jun 01, 2025
Primary Outcome
Successful adjustment procedure at 16 ±2 weeks in 85% of attempts.
Summary
The purpose of this study is to evaluate the function of the adjustment procedure with the
 Spatz4 in subjects with a BMI ≥ 27.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06373666
Device Trial